PLA2G2A and coronary artery disorder: In humans, although polymorphisms in the Pla2g2a gene affecting sPLA2-IIA levels have been associated with metabolic disorders, such as coronary heart disease and type II diabetes [63–65], no genetic link between Pla2g2a and FTLD or other neurodegenerative diseases has been reported.